Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 32911-32920 Newer>

The Motley Fool November 7, 2008 Morgan Housel	Blackstone Unravels It's been a short, strange, and embarrassing existence as a public company for The Blackstone Group.
The Motley Fool November 7, 2008 Rich Smith	The Dolby Dilemma Just as it's done for three years running, Dolby trounced the Street's predictions, and the stock's enjoying a well-deserved bounce in response. But, should you buy it?
The Motley Fool November 7, 2008 Tim Beyers	The Best Stock Idea I've Ever Seen If you're a long-term investor who's hoping to profit tomorrow from today's panic, invest in firms that exhibit each of the three following winning traits.
The Motley Fool November 7, 2008 Brian Orelli	Onyx -- Still Waiting Onyx licenses a pre-clinical drug from England's BTG International -- but it's got a new problem to worry about.
The Motley Fool November 7, 2008 Brian Orelli	Teva's Steady Growth Generic-drug maker Teva Pharmaceuticals has been a good defensive play during the severe downturn in the market.
The Motley Fool November 7, 2008 Morgan Housel	Wells Fargo Doubles Down Wells Fargo raises $11 billion in fresh equity by issuing common stock, down from the $20 billion it planned on raising to help usher in its pending of acquisition of Wachovia.
The Motley Fool November 7, 2008 Alex Dumortier	Nasdaq Is a Buy! Patient investors have been given an excellent opportunity to own NASDAQ OMX at an attractive price.
The Motley Fool November 7, 2008 Rick Aristotle Munarriz	Why Is Everybody Picking on Disney? Sure, shares of the family entertainment giant have fallen by 35% since peaking in May, but Disney is doing better than you think.
The Motley Fool November 7, 2008 Brian Orelli	Thinning Out the Pipeline The FDA says no to diet drugs from Sanofi-Aventis and Pfizer.
The Motley Fool November 7, 2008 Rick Aristotle Munarriz	Priceline Is Laughing at You Priceline's third-quarter report makes ten straight quarters that it has blown past analyst's expectations.
<Older 32911-32920 Newer> Return to current articles.